查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106322

細胞農業原料市場：預測至2034年－按原料類型、原料、技術、應用、最終用戶和地區分類的全球分析

Cellular Agriculture Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Type, Source, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球細胞農業原料市場預計到 2026 年將達到 166 億美元，並在預測期內以 19.2% 的複合年成長率成長，到 2034 年達到 478 億美元。

細胞農業原料是指透過體外細胞培養、組織工程和微發酵等製程生產的生物化合物、蛋白質、脂質和細胞物質，而非透過傳統的畜牧養殖或一般作物種植而獲得。這些原料是在受控的生物反應器環境中，使用特定培養基培養動物細胞、微生物或真菌生質能而製成的。在反應器中，透過支架材料、生長因子訊號傳導和生物製程最佳化，誘導細胞分化和蛋白質表達，從而生成機能性食品成分、生物活性物質以及用於營養、醫藥和化妝品領域的特殊原料。

對永續性的需求是驅動力。

在全球日益成長的減少食品生產對環境影響的壓力下，對細胞農業原料的投資正在加速成長。與傳統畜牧業相比，細胞農業原料能夠顯著減少土地利用、水資源消耗和溫室氣體排放。大型食品公司和機構投資者正投資細胞農業新創公司和生產設施，以實現淨零排放供應鏈的目標。同時，消費者對符合道德規範且環境記錄透明的原料的需求，也推高了細胞培養產品的溢價。

生產規模的限制

目前，細胞培養基、生物反應器基礎設施和品管檢測的高昂成本構成了細胞農業原料實現商業化規模生產的巨大經濟障礙。食品級生長因子和專用支架材料的全球產能有限，限制了批次規模的擴大。此外，大多數司法管轄區對新型細胞衍生原料的法規核准流程仍在製定中，導致市場准入延遲，並增加了生產設施投資的資本風險。

開發成醫藥級

細胞農業平台能夠以穩定的批次品質生產高純度膠原蛋白、明膠和生物活性蛋白，其成功示範正在為製藥和膳食補充劑行業創造巨大的商機，這些行業對純度標準和可追溯的供應鏈有著嚴格的要求。醫療設備製造商和再生醫學公司也正日益評估細胞培養原料在創傷治療、組織支架和藥物遞送等方面的應用，從而開闢出利潤豐厚的細分市場，抵消食品行業生產成本方面的挑戰。

監理核准的不確定性

主要市場對細胞培養食品配料的法律規範不斷演變且缺乏統一標準，導致核准時間、標籤要求和安全評估標準等方面存在顯著的區域差異，從而造成商業不確定性。代表傳統農業的遊說團體和質疑細胞衍生配料「天然性」的消費者團體的反對，可能會影響監管的嚴格程度和社會接受度。此外，針對新興食品技術的貿易壁壘可能會限制跨境食材貿易，阻礙市場發展。

新型冠狀病毒（COVID-19）的影響：

新冠感染疾病導致加工廠停工和勞動力短缺，暴露了全球肉類供應鏈的許多脆弱性。這加速了投資者和企業對分散式細胞農業生產系統的興趣，因為這類系統受疫情影響較小。疫情後，人們對供應鏈韌性和生物安全的重視，進一步強化了細胞衍生原料平台的戰略意義；同時，政府對生物技術基礎設施和糧食安全研究的投入，也為擴大細胞農業規模提供了更多支持。

在預測期內，培養蛋白原料細分市場預計將佔據最大的市場佔有率。

鑑於蛋白質是細胞農業在食品和營養補充劑應用領域中最具價值和功能意義的產出，預計在預測期內，培養蛋白質原料領域將佔據最大的市場佔有率。領先的食品製造商致力於生產混合型和全細胞衍生肉品，他們需要穩定、高品質的蛋白質原料，以複製傳統動物蛋白質的胺基酸組成和功能特性。隨著培養蛋白生產成本效益的提高，持續的採購需求將會被推動。

預計在預測期內，發酵輔助細胞培養領域將呈現最高的複合年成長率。

在預測期內，發酵輔助細胞培養領域預計將呈現最高的成長率，這主要得益於其技術優勢，例如相比完整的動物細胞培養系統，其資本密集度更低、規模化速度更快。微生物和真菌微發酵平台能夠以更高的產量和更低的培養基成本生產複雜的蛋白質和生物活性化合物，從而加速商業性化進程，並吸引那些希望在不投資大規模生物反應器基礎設施的情況下，實現細胞農業領域多元化發展的原料生產商與其建立生產合作夥伴關係。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這是因為美國擁有最先進的細胞農業法規結構，透過美國食品藥物管理局(FDA) 和美國農業部 (USDA) 之間的聯合監管協議，其核准流程比其他地區更為清晰。包括 UPSIDE Foods, Inc. 和 GOOD Meat 在內的領先細胞農業公司總部均設在北美，培養肉產品已獲得監管部門的批准。大量的創業投資和學術研究計畫​​也為其持續的創新領先地位提供了支持。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這是因為新加坡、日本和韓國等國政府主導的糧食舉措正積極支持細胞農業的發展，包括專項研究經費和簡化的法規結構。該地區快速成長的城市人口和國內耕地短缺，催生了對替代蛋白質生產方式的強勁結構性需求；同時，該地區獨特的生物技術製造技術和成熟的發酵產業也為擴大細胞衍生原料的生產規模提供了基礎能力。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球細胞農業原料市場：依原料類型分類

  • 培養蛋白原料
  • 養殖油脂原料
  • 細胞培養乳成分
  • 細胞衍生膠原膠原蛋白
  • 細胞衍生明膠
  • 細胞衍生的生物活性成分
  • 其他成分類型

第6章：全球細胞農業原料市場：依原料分類

  • 動物細胞
  • 微生物細胞庫
  • 真菌細胞基部
  • 海洋來源細胞庫
  • 鳥類細胞基地
  • 其他來源

第7章：全球細胞農業原料市場：依技術分類

  • 幹細胞技術
  • 組織工程
  • 發酵輔助細胞培養
  • 基於支架的培養
  • 無支架培養
  • 生物列印技術

第8章：全球細胞農業原料市場：依應用領域分類

  • 食品/飲料
  • 人造肉品
  • 乳製品替代品
  • 營養保健品
  • 製藥
  • 化妝品和個人護理
  • 寵物食品

第9章：全球細胞農業原料市場：依最終用戶分類

  • 食品製造商
  • 原料生產商
  • 生技公司
  • 製藥公司
  • 化妝品製造商
  • 研究機構
  • 契約製造組織

第10章 全球細胞農業原料市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • UPSIDE Foods, Inc.
  • GOOD Meat
  • Mosa Meat BV
  • Aleph Farms Ltd.
  • Meatable BV
  • Believer Meats Ltd.
  • BlueNalu, Inc.
  • Wildtype Inc.
  • Finless Foods, Inc.
  • TurtleTree Labs Pte. Ltd.
  • Orbillion Bio, Inc.
  • SCiFi Foods, Inc.
  • New Age Meats
  • Steakholder Foods Ltd.
  • Cult Food Science Corp.
  • Eat Just, Inc.
  • Future Meat Technologies Ltd.
Product Code: SMRC38526

According to Stratistics MRC, the Global Cellular Agriculture Ingredients Market is accounted for $16.6 billion in 2026 and is expected to reach $47.8 billion by 2034 growing at a CAGR of 19.2% during the forecast period. Cellular agriculture ingredients refer to biological compounds, proteins, fats, and cellular materials produced through in vitro cell culture, tissue engineering, and precision fermentation processes rather than traditional animal agriculture or conventional crop cultivation. These ingredients are manufactured by cultivating animal cells, microbial organisms, or fungal biomass in controlled bioreactor environments using defined growth media, where cellular differentiation and protein expression are directed through scaffold materials, growth factor signaling, and bioprocess optimization to yield functional food components, bioactive materials, and specialty ingredients for nutritional, pharmaceutical, and cosmetic applications.

Market Dynamics:

Driver:

Sustainability Imperative Drive

Intensifying global pressure to reduce the environmental footprint of food production is accelerating investment in cellular agriculture ingredients that offer dramatically lower land use, water consumption, and greenhouse gas emissions compared to conventional livestock farming. Major food corporations and institutional investors are channeling capital toward cellular agriculture startups and production facilities as part of net-zero supply chain commitments, while consumer demand for ethically produced ingredients with transparent environmental credentials supports premium pricing for cell-cultured products.

Restraint:

Production Scale Limitations

The current high cost of cell culture media, bioreactor infrastructure, and quality control testing creates significant economic barriers to achieving price-competitive production volumes for cellular agriculture ingredients at commercial scale. Limited global manufacturing capacity for food-grade growth factors and specialized scaffold materials constrains batch size expansion, while regulatory approval pathways for novel cellular ingredients remain under development in most jurisdictions, which delays market entry and increases capital risk for production facility investments.

Opportunity:

Pharmaceutical Grade Expansion

The demonstrated ability of cellular agriculture platforms to produce high-purity collagen, gelatin, and bioactive proteins with consistent batch quality is creating substantial opportunities in pharmaceutical and nutraceutical applications that require rigorous purity standards and traceable supply chains. Medical device manufacturers and regenerative medicine companies are increasingly evaluating cell-cultured ingredients for wound healing, tissue scaffolding, and drug delivery applications, which opens high-margin specialty markets that offset food-sector production cost challenges.

Threat:

Regulatory Approval Uncertainty

Evolving and inconsistent regulatory frameworks for cell-cultured food ingredients across major markets create significant commercial uncertainty, as approval timelines, labeling requirements, and safety assessment standards vary substantially between jurisdictions. Opposition from conventional agriculture lobbying groups and consumer advocacy organizations questioning the naturalness of cellular ingredients can influence regulatory stringency and public acceptance, while trade barriers targeting novel food technologies may restrict cross-border ingredient commerce and fragment market development.

Covid-19 Impact:

COVID-19 exposed critical vulnerabilities in global meat supply chains through processing facility shutdowns and workforce disruptions, which accelerated investor and corporate interest in decentralized cellular agriculture production systems that are less susceptible to pandemic-related operational interruptions. Post-pandemic emphasis on supply chain resilience and biosecurity has strengthened the strategic rationale for cellular ingredient platforms, while government funding for biotechnology infrastructure and food security research has increased support for cellular agriculture scale-up initiatives.

The cultivated protein ingredients segment is expected to be the largest during the forecast period

The cultivated protein ingredients segment is expected to account for the largest market share during the forecast period, due to proteins representing the highest-value and most functionally critical cellular agriculture output for food and nutraceutical applications. Major food manufacturers seeking to develop hybrid and fully cell-based meat products require consistent, high-quality protein ingredients that replicate the amino acid profiles and functional properties of conventional animal proteins, which drives sustained procurement demand as cultivated protein production achieves cost parity milestones.

The fermentation-assisted cell culture segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the fermentation-assisted cell culture segment is predicted to witness the highest growth rate, driven by the technology's lower capital intensity and faster scale-up trajectory compared to full animal cell cultivation systems. Precision fermentation platforms leveraging microbial and fungal hosts can produce complex proteins and bioactive compounds at significantly higher yields and lower media costs, which accelerates commercial viability and attracts manufacturing partnerships from ingredient companies seeking to diversify into cellular agriculture without full bioreactor infrastructure investment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the United States maintaining the most advanced cellular agriculture regulatory framework with FDA and USDA joint oversight protocols that provide clearer approval pathways than other jurisdictions. Leading cellular agriculture companies including UPSIDE Foods, Inc. and GOOD Meat are headquartered in North America and have secured regulatory approvals for cultivated meat products, while substantial venture capital investment and academic research programs support continued innovation leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to government-led food security initiatives in Singapore, Japan, and South Korea that actively support cellular agriculture development through dedicated research funding and streamlined regulatory frameworks. Rapidly expanding urban populations and limited domestic agricultural land in the region create strong structural demand for alternative protein production methods, while regional biotechnology manufacturing expertise and established fermentation industries provide foundational capabilities for cellular ingredient scale-up.

Key players in the market

Some of the key players in Cellular Agriculture Ingredients Market include UPSIDE Foods, Inc., GOOD Meat, Mosa Meat B.V., Aleph Farms Ltd., Meatable B.V., Believer Meats Ltd., BlueNalu, Inc., Wildtype Inc., Finless Foods, Inc., TurtleTree Labs Pte. Ltd., Orbillion Bio, Inc., SCiFi Foods, Inc., New Age Meats, Steakholder Foods Ltd., Cult Food Science Corp., Eat Just, Inc. and Future Meat Technologies Ltd.

Key Developments:

In June 2026, UPSIDE Foods, Inc. secured FDA approval for its next-generation cultivated chicken protein ingredient line, enabling commercial supply to food manufacturers across the United States for hybrid product formulations.

In May 2026, Mosa Meat B.V. expanded its European production facility with additional bioreactor capacity dedicated to cultivated beef fat ingredient manufacturing for the continental foodservice market.

In April 2026, Aleph Farms Ltd. launched a cultivated collagen ingredient platform targeting pharmaceutical and cosmetic applications, achieving consistent triple-helix structure replication for tissue engineering use cases.

Ingredient Types Covered:

  • Cultivated Protein Ingredients
  • Cultivated Fat Ingredients
  • Cell-Cultured Dairy Ingredients
  • Cell-Based Collagen
  • Cell-Derived Gelatin
  • Cellular Bioactive Ingredients
  • Other Ingredient Types

Sources Covered:

  • Animal Cell-Based
  • Microbial Cell-Based
  • Fungal Cell-Based
  • Marine Cell-Based
  • Avian Cell-Based
  • Other Sources

Technologies Covered:

  • Stem Cell Technology
  • Tissue Engineering
  • Fermentation-Assisted Cell Culture
  • Scaffold-Based Cultivation
  • Scaffold-Free Cultivation
  • Bioprinting Technology

Applications Covered:

  • Food and Beverages
  • Alternative Meat Products
  • Dairy Alternatives
  • Nutraceuticals
  • Pharmaceuticals
  • Cosmetics and Personal Care
  • Pet Food

End Users Covered:

  • Food Manufacturers
  • Ingredient Manufacturers
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Cosmetic Manufacturers
  • Research Institutions
  • Contract Manufacturing Organizations

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Cellular Agriculture Ingredients Market, By Ingredient Type

  • 5.1 Cultivated Protein Ingredients
  • 5.2 Cultivated Fat Ingredients
  • 5.3 Cell-Cultured Dairy Ingredients
  • 5.4 Cell-Based Collagen
  • 5.5 Cell-Derived Gelatin
  • 5.6 Cellular Bioactive Ingredients
  • 5.7 Other Ingredient Types

6 Global Cellular Agriculture Ingredients Market, By Source

  • 6.1 Animal Cell-Based
  • 6.2 Microbial Cell-Based
  • 6.3 Fungal Cell-Based
  • 6.4 Marine Cell-Based
  • 6.5 Avian Cell-Based
  • 6.6 Other Sources

7 Global Cellular Agriculture Ingredients Market, By Technology

  • 7.1 Stem Cell Technology
  • 7.2 Tissue Engineering
  • 7.3 Fermentation-Assisted Cell Culture
  • 7.4 Scaffold-Based Cultivation
  • 7.5 Scaffold-Free Cultivation
  • 7.6 Bioprinting Technology

8 Global Cellular Agriculture Ingredients Market, By Application

  • 8.1 Food and Beverages
  • 8.2 Alternative Meat Products
  • 8.3 Dairy Alternatives
  • 8.4 Nutraceuticals
  • 8.5 Pharmaceuticals
  • 8.6 Cosmetics and Personal Care
  • 8.7 Pet Food

9 Global Cellular Agriculture Ingredients Market, By End User

  • 9.1 Food Manufacturers
  • 9.2 Ingredient Manufacturers
  • 9.3 Biotechnology Companies
  • 9.4 Pharmaceutical Companies
  • 9.5 Cosmetic Manufacturers
  • 9.6 Research Institutions
  • 9.7 Contract Manufacturing Organizations

10 Global Cellular Agriculture Ingredients Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 UPSIDE Foods, Inc.
  • 13.2 GOOD Meat
  • 13.3 Mosa Meat B.V.
  • 13.4 Aleph Farms Ltd.
  • 13.5 Meatable B.V.
  • 13.6 Believer Meats Ltd.
  • 13.7 BlueNalu, Inc.
  • 13.8 Wildtype Inc.
  • 13.9 Finless Foods, Inc.
  • 13.10 TurtleTree Labs Pte. Ltd.
  • 13.11 Orbillion Bio, Inc.
  • 13.12 SCiFi Foods, Inc.
  • 13.13 New Age Meats
  • 13.14 Steakholder Foods Ltd.
  • 13.15 Cult Food Science Corp.
  • 13.16 Eat Just, Inc.
  • 13.17 Future Meat Technologies Ltd.

List of Tables

  • Table 1 Global Cellular Agriculture Ingredients Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Cellular Agriculture Ingredients Market Outlook, By Ingredient Type (2023-2034) ($MN)
  • Table 3 Global Cellular Agriculture Ingredients Market Outlook, By Cultivated Protein Ingredients (2023-2034) ($MN)
  • Table 4 Global Cellular Agriculture Ingredients Market Outlook, By Cultivated Fat Ingredients (2023-2034) ($MN)
  • Table 5 Global Cellular Agriculture Ingredients Market Outlook, By Cell-Cultured Dairy Ingredients (2023-2034) ($MN)
  • Table 6 Global Cellular Agriculture Ingredients Market Outlook, By Cell-Based Collagen (2023-2034) ($MN)
  • Table 7 Global Cellular Agriculture Ingredients Market Outlook, By Cell-Derived Gelatin (2023-2034) ($MN)
  • Table 8 Global Cellular Agriculture Ingredients Market Outlook, By Cellular Bioactive Ingredients (2023-2034) ($MN)
  • Table 9 Global Cellular Agriculture Ingredients Market Outlook, By Other Ingredient Types (2023-2034) ($MN)
  • Table 10 Global Cellular Agriculture Ingredients Market Outlook, By Source (2023-2034) ($MN)
  • Table 11 Global Cellular Agriculture Ingredients Market Outlook, By Animal Cell-Based (2023-2034) ($MN)
  • Table 12 Global Cellular Agriculture Ingredients Market Outlook, By Microbial Cell-Based (2023-2034) ($MN)
  • Table 13 Global Cellular Agriculture Ingredients Market Outlook, By Fungal Cell-Based (2023-2034) ($MN)
  • Table 14 Global Cellular Agriculture Ingredients Market Outlook, By Marine Cell-Based (2023-2034) ($MN)
  • Table 15 Global Cellular Agriculture Ingredients Market Outlook, By Avian Cell-Based (2023-2034) ($MN)
  • Table 16 Global Cellular Agriculture Ingredients Market Outlook, By Other Sources (2023-2034) ($MN)
  • Table 17 Global Cellular Agriculture Ingredients Market Outlook, By Technology (2023-2034) ($MN)
  • Table 18 Global Cellular Agriculture Ingredients Market Outlook, By Stem Cell Technology (2023-2034) ($MN)
  • Table 19 Global Cellular Agriculture Ingredients Market Outlook, By Tissue Engineering (2023-2034) ($MN)
  • Table 20 Global Cellular Agriculture Ingredients Market Outlook, By Fermentation-Assisted Cell Culture (2023-2034) ($MN)
  • Table 21 Global Cellular Agriculture Ingredients Market Outlook, By Scaffold-Based Cultivation (2023-2034) ($MN)
  • Table 22 Global Cellular Agriculture Ingredients Market Outlook, By Scaffold-Free Cultivation (2023-2034) ($MN)
  • Table 23 Global Cellular Agriculture Ingredients Market Outlook, By Bioprinting Technology (2023-2034) ($MN)
  • Table 24 Global Cellular Agriculture Ingredients Market Outlook, By Application (2023-2034) ($MN)
  • Table 25 Global Cellular Agriculture Ingredients Market Outlook, By Food and Beverages (2023-2034) ($MN)
  • Table 26 Global Cellular Agriculture Ingredients Market Outlook, By Alternative Meat Products (2023-2034) ($MN)
  • Table 27 Global Cellular Agriculture Ingredients Market Outlook, By Dairy Alternatives (2023-2034) ($MN)
  • Table 28 Global Cellular Agriculture Ingredients Market Outlook, By Nutraceuticals (2023-2034) ($MN)
  • Table 29 Global Cellular Agriculture Ingredients Market Outlook, By Pharmaceuticals (2023-2034) ($MN)
  • Table 30 Global Cellular Agriculture Ingredients Market Outlook, By Cosmetics and Personal Care (2023-2034) ($MN)
  • Table 31 Global Cellular Agriculture Ingredients Market Outlook, By Pet Food (2023-2034) ($MN)
  • Table 32 Global Cellular Agriculture Ingredients Market Outlook, By End User (2023-2034) ($MN)
  • Table 33 Global Cellular Agriculture Ingredients Market Outlook, By Food Manufacturers (2023-2034) ($MN)
  • Table 34 Global Cellular Agriculture Ingredients Market Outlook, By Ingredient Manufacturers (2023-2034) ($MN)
  • Table 35 Global Cellular Agriculture Ingredients Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 36 Global Cellular Agriculture Ingredients Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
  • Table 37 Global Cellular Agriculture Ingredients Market Outlook, By Cosmetic Manufacturers (2023-2034) ($MN)
  • Table 38 Global Cellular Agriculture Ingredients Market Outlook, By Research Institutions (2023-2034) ($MN)
  • Table 39 Global Cellular Agriculture Ingredients Market Outlook, By Contract Manufacturing Organizations (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.